Mithplatins: Mithramycin SA‐Pt(II) Complex Conjugates for the Treatment of Platinum‐Resistant Ovarian Cancers is a research paper published in ChemMedChem (2022). On theSindex it has a DataRank of 0. It has been cited 2 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: P30CA177558
National Institutes of Health
Grant: S10 OD28690-01
NCI NIH HHS
Grant: R01 CA243529
NIH HHS
Grant: S10 OD028690
European Commission
Grant: 243529
Improved Novel Eco-Friendly Bleaching System for Cotton Using Enzyme and Ultrasound Processes
National Institutes of Health
Grant: 1S10OD028690-01
Bruker AVANCE NEO 600 MHz High-Performance Digital NMR Spectrometer
National Institutes of Health
Grant: 5R01CA243529-03
Mechanistic and pharmacologic studies of selective mithramycin analogues targeting EWS-FLI1 in Ewing sarcoma
Fundação para a Ciência e a Tecnologia, I.P.
Grant: PTDC/CCI-BIO/29266/2017
Deep Drug Discovery and Deployment
National Institutes of Health
Grant: 3P30CA177558-01S1
CTRP Supplement
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals